Status:

UNKNOWN

Premature Rupture Membranes and tPTL: a Personalised Approach (PROMPT)

Lead Sponsor:

Chelsea and Westminster NHS Foundation Trust

Conditions:

Preterm Rupture of Membranes

Threatened Preterm Labor

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

Preterm birth (less than 37 weeks) affect approximately 8% of babies in the UK and is the worldwide leading cause of death in children under the age of 5. Subclinical infection affects approximately 5...

Detailed Description

Overall 10-15% of women delivering before 37 weeks have intraamniotic infection and of those delivering before 32 weeks have 50% chance. Consequently, since infection is one of the most important caus...

Eligibility Criteria

Inclusion

  • Pregnant women between 23+0 weeks and 34 weeks gestation.
  • Admitted with signs and symptoms of threatened PTL with positive fetal fibronectin of 200ng/mL or clinical confirmation of preterm rupture of membranes
  • Singleton pregnancy
  • The ability to understand and sign a written informed consent form, prior to participation in any screening procedures and must be willing to comply with all study requirements.
  • Women must be aged 18 years or older.
  • \-

Exclusion

  • Chorioamnionitis: Defined as maternal temperature was elevated to 37.8°C and two or more of the following criteria were present: uterine tenderness, malodorous vaginal discharge, maternal leucocytosis (\>15 000 cells/mm3), maternal tachycardia (\>100 beats/min) and fetal tachycardia (\>160 beats/min).
  • Multiple pregnancy
  • Uterine contractions \>2:10 and evidence on tocogram
  • Maternal infections such as HIV and hepatitis
  • Clinical suspicion of placental abruption
  • Evidence of meconium stained liquor
  • Fetal abnormality or growth restriction
  • Abnormal fetal heart rate pattern
  • Maternal pathologies in which preterm termination of pregnancy is required.
  • \-

Key Trial Info

Start Date :

September 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2025

Estimated Enrollment :

276 Patients enrolled

Trial Details

Trial ID

NCT04878978

Start Date

September 1 2021

End Date

June 1 2025

Last Update

August 18 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.